|
|
 |
|
PharmaVitae: Company Comparator Tool
IntroductionThe Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.Reasons to Purchase*Compare players by US or global forecast therapy area sales and portfolio breakdown measures to identify winners and losers over the next seven years*Drill down to the individual drug forecast level for each company, identifying the key drivers behind forecast performance over the next seven years*Access over 150,000 continuously tracked data points analyzing current and future trends in the pharmaceutical and biotech arenas
|
 |
04/18/2009 |
$45600.00 |
| |
|
|
|
The Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Development Strategies
During the next ten years, the blood banking market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation is more critical than underlying technology....
|
|
|
$29400.00 |
| |
|
|
|
The Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$24500.00 |
| |
|
|
|
The 2009 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....
|
|
|
$23700.00 |
| |
|
|
|
Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market countries in order to sustain their revenue growth. While some countries, with double digit growth rates present tremendous opportunities, there are also many obstacles that need to be overcome.
|
|
01/09/2008 |
$15200.00 |
| |
|
|
|
The US Cancer Diagnostics Market
This report presents a comprehensive analysis of the US cancer diagnostics market, including: - Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$8900.00 |
| |
|
|
|
The US Blood Banking Market Through 2013
This report presents a comprehensive analysis of the US blood banking market, including: - Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with signifi
|
|
|
$8200.00 |
| |
|
|
|
The US Coagulation Market, 2009-2018
This report presents a comprehensive analysis of the US coagulation market, including: - Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads....
|
|
|
$7100.00 |
| |
|
|
|
Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
Emerging Clinical Trial LocationsMarket dynamics and the changing healthcare and regulatory environmentReport OverviewPharma and biotech companies are attempting to combat escalating R&D costs and lengthy clinical trial timelines by improving patient recruitment and the efficiency of clinical trial analysis/reporting. The biopharmaceutical market has recognized the opportunities and advantages that exist by conducting clinical trials in emerging markets....
|
|
06/22/2009 |
$6710.00 |
| |
|
|
|
The Japanese Cancer Diagnostics Market
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: - Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$6700.00 |
| |
|
|
|
The Japanese Blood Banking Market Through 2013
This report presents a comprehensive analysis of the Japanese blood banking market, including: - Major issues pertaining to the Japanese blood banking practice, as well as key economic, regulatory, demographic, social and technological trends
|
|
|
$6600.00 |
| |
|
|
|
Emerging Markets Series: The Pharmaceutical Market of Saudi Arabia
IntroductionThe Saudi Arabian pharmaceutical sector is becoming increasingly attractive for multinationals to enter driven by the expansion of private healthcare and altering patient demographics and also for domestic generics companies as the government looks to evolve its cost saving strategies.Scope*Overview of challenges faced by the Saudi Arabian healthcare system and a review of the healthcare financing system reforms*Analysis of trends observed in the pharmaceutical sector and the development of the healthcare insurance sector*Update of healthcare reforms undertaken in the Kingdom and thought-leader insights into future changes to be implemented*Commercial implications of the reforms for insurers, multinational and domestic pharma companies, supported by Datamonitor strategic recommendationsHighlightsHealthcare reforms in Saudi Arabia will increase access to healthcare services and pharmaceuticals as the penetration of cooperative health insurance increases across the Kingdom....
|
|
06/01/2009 |
$5700.00 |
| |
|
|
|
Emerging Markets Series: The Pharmaceutical Market of Poland
IntroductionPoland's economy has grown from strength to strength in the past 5 years, and despite the global economic downturn Poland is expected to maintain positive growth through 2010. However, concern exists over intellectual property and inconsistent drug reimbursement....
|
|
06/04/2009 |
$5700.00 |
| |
|
|
|
The Japanese Coagulation Market, 2009-2018
This report presents a comprehensive analysis of the Japanese coagulation market, including: - Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in Japanese hospitals and commercial laboratories, including typical coagulation daily work loads....
|
|
|
$5400.00 |
| |
|
|
|
The German Cancer Diagnostics Market
This report presents a comprehensive analysis of the German cancer diagnostics market, including: - Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$4900.00 |
| |
|
|
|
The French Cancer Diagnostics Market
This report presents a comprehensive analysis of the French cancer diagnostics market, including: - Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$4900.00 |
| |
|
|
|
The UK Cancer Diagnostics Market
This report presents a comprehensive analysis of the UK cancer diagnostics market, including: - Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$4900.00 |
| |
|
|
|
The Spanish Cancer Diagnostics Market
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: - Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$4900.00 |
| |
|
|
|
|